MT Laws Week 11

Comprehensive Dangerous Drugs Act of 2002

REPUBLIC ACT NO. 9165 shall be known and cited as the “___”

RA 6425

REPUBLIC ACT NO. 9165 repeals ___

500,000 to 10,000,000

Section 11. Possession of Dangerous Drugs

• The penalty of life imprisonment to death and a fine ranging from ___ to ___

opium ; morphine ; heroin; cocaine ; marijuana resin or marijuana resin oil

Section 11. Possession of Dangerous Drugs

• 10 grams of:

  • ___

  • ___

  • ___

  • ___

  • ___ or ___

methamphetamine hydrochloride

Section 11. Possession of Dangerous Drugs

• 50 grams of:

  • ___

marijuana

Section 11. Possession of Dangerous Drugs

• 500 grams of:

  • ___

screening test and confirmatory test

Section 36. Authorized Drug Testing.

• The drug testing shall employ, among others, two (2) testing methods ___ and ___

one year

Drug test certificates issued by accredited drug testing centers shall be valid for a ___ period from the date of issue which may be used for other purposes

Random Drug Testing

Students and Employees may undergo

six years and one day

All persons charged before the prosecutor's office with a criminal offense having an imposable penalty of imprisonment of not less than ___ and ___ shall have to undergo a mandatory drug test

six years and one day to twelve years

Section 37. Issuance of False or Fraudulent Drug Test Results.

• Any person authorized, licensed or accredited under this Act and its implementing rules to conduct drug examination or test, who issues false or fraudulent drug test results knowingly, willfully or through gross negligence, shall suffer the penalty of imprisonment ranging from ___ to ___

100,000 ; 500,000

Section 37. Issuance of False or Fraudulent Drug Test Results.

• Any person authorized, licensed or accredited under this Act and its implementing rules to conduct drug examination or test, who issues false or fraudulent drug test results knowingly, willfully or through gross negligence, shall suffer a fine of ___ to ___

revocation of license

Section 37. Issuance of False or Fraudulent Drug Test Results.

• Any person authorized, licensed or accredited under this Act and its implementing rules to conduct drug examination or test, who issues false or fraudulent drug test results knowingly, willfully or through gross negligence, shall suffer a ___

closure of the drug testing center

Section 37. Issuance of False or Fraudulent Drug Test Results.

• Any person authorized, licensed or accredited under this Act and its implementing rules to conduct drug examination or test, who issues false or fraudulent drug test results knowingly, willfully or through gross negligence, shall suffer the ___

24 hours

Section 38. Laboratory Examination or Test on Apprehended/Arrested Offenders.

• Subject to Section 15 of this Act, any person apprehended or arrested for violating the provisions of this Act shall be subjected to screening laboratory examination or test within ___

15 days

If found to be positive, the results of the screening laboratory examination or test shall be challenged within ___

gas chromatograph / mass spectrometry

after receipt of the result through a confirmatory test conducted in any accredited analytical laboratory equipment with a ___ / ___ equipment or some such modern and accepted method

Government Drug Testing Laboratories

Ownership

• ___ are operated and maintained partially or wholly by the national, provincial, city, or municipal government, or other political unit, or by any department, division, board, or agency thereof.

Private Drug Testing Laboratories

Ownership

• ___ are privately owned, established, and operated with funds through donation, principal, investment, or other means, by any individual, corporation, association, or organization.

Institution-based Drug Testing Laboratories

Institutional Character

• ___ are located within the premises and operates as part of an institution (e.g., hospital, medical facilities for overseas workers and seafarers).

Freestanding Drug Testing Laboratories

Institutional Character

• ___ are located outside the an institution and operate independently.

Screening laboratories

Service Capability

• ___ are capable of performing screening tests.

Confirmatory laboratories

Service Capability

• ___ are capable of performing qualitative and quantitative examinations of dangerous drugs from the specimen.

pathologist or licensed physician with clinical laboratory management training

Freestanding screening DTLs must be headed by:

• ___ or ___

licensed physician ; chemist ; medical technologist ; pharmacist ; chemical engineer

Institution-based screening DTLs must be headed by a

• ___

• ___

• ___

• ___

• ___

pathologist or chemist with Master's degree in chemistry or biochemistry.

Confirmatory DTLs must be headed by

• ___ or ___

Chemist ; Medical Technologist ; Pharmacist ; Chemical engineer

Certified Drug Test Analyst (DTA)

• ___

• ___

• ___

• ___

10

A licensed physician is allowed to supervise at least _ DTLs

chemists, medical technologists, pharmacists, or chemical engineers

Qualified professionals such ___, ___, ___, or ___ may perform the tasks of a drug analyst

specimen collector

A ___ is a member of the laboratory personnel who collects specimens from a patient, client, or subject.

East Avenue Medical Center

The National Reference Laboratory of toxicology, including drug test is the ___

20 sqm ; 10 sqm

Screening DTL

• Floor Area: ___

• Work Area: ___

60 sqm ; 30 sqm

Confirmatory DTL

• Floor Area: ___

• Work Area: ___

time of collection to receipt

These steps require the confirmation of the applicant's identity and a custody and control form (CCF) must be used from the ___ to ___ by the laboratory

60 mL

urination and to provide at least ___ collected in single specimen

30 mL

urination and to provide at least ___ collected in split specimen

laboratory validity testing

A tampered specimen is sent to the ___ and the authorized specimen collector shall document the tampering on the chain of custody form (CCF) with appropriate remarks

temperature ; volume ; physical characteristics

After the client/donor/subject hands the specimen/the authorized specimen collector must measure the ___, check ___, and inspect its ___

tamper-evident label/seal

A ___ must be used to secure the specimen container

authorized specimen collector and subject

Both the ___ and the ___ must affix their signature on the seal together with the date and time of collection.

Screening test (qualitative test)

___ refers to a test to eliminate negative specimens from further consideration and to identify the presumptively positive specimens that requires confirmatory testing.

Confirmatory test (quantitative test)

___ refers to the analytical procedure used to identify and quantify the presence of a specific drug or metabolite, which is independent of the initial test and which uses a different technique and chemical principle from that of the screening test in order to ensure reliability and accuracy.

antibody-antigen reaction

Immunoassay: These methods are used for preliminary screening based on ___.

chromatographic method

Chromatography. The separation of a mixture is the main outcome of the ___. In this process, a mixture of the substance is separated in a stationary medium.

Hyphenated technique

___: Combination of two sophisticated technologies (i.e., gas chromatography - mass spectrometry or GC-MS) or other modern and acceptable techniques (i.e., LC-MS, GC-MS-MS, or LC-MS-MS).

1 year

Screening test Accreditation valid for: ___

2 year

Confirmatory test Accreditation valid for: ___

positive screening test results

All specimens with ___ are submitted for confirmation before a final report will be issued.

analyst and the head of the DTL

All test results obtained either through screening or confirmatory testing shall bear the signature of the ___ and the ___.

one year

All test results obtained either through screening or confirmatory testing are valid for ___ from the date of issue.

90 days

The application for renewal of accreditation shall be filed ___ before the expiry date.

three weeks

The laboratory shall submit to the NRL the results of the test performed on the unknown sample within ___ after the receipt of the test sample

Amphetamines

___: Narcolepsy, Attentional deficit disorder

Methamphetamine Hydrochloride

Amphetamines

• Derivative of methamphetamine: ___

Methylenedioxymethamphetamine (MDMA)

Amphetamines

• Derivative of amphetamines: ___

Anabolic Steroids

___: Increasing muscle mass

Cannabinoids

___: Hallucinogen and induce euphoria

11-nor-Delta(9)-tetrahydrocannabinol-9-COOH (THC)

Cannabinoids

• Urine metabolite: ___

Cocaine

___: Local anesthetic for nasopharyngeal surgery

Benzoylecgonine

Cocaine

• Urine metabolite: ___

Opiates

___: Analgesia, Sedation & Anesthesia

N-acetylmorphine & Morphine

Opiates

• Major metabolites of Heroin: ___

Phencyclidine

___: Analgesia & Anesthesia

Phencyclidine HCl

Phencyclidine

• Major metabolite: ___

Sedative Hypnotics

___: CNS depressants

Secobarbital

Sedative Hypnotics

• Major metabolite: ___

Lysergic Acid Diethylamide

___: Hallucinogen

2-oxo-3-hydroxy LSD

Lysergic Acid Diethylamide

• Major metabolite: ___

Methaqualone

___: Hallucinogen

Piperazines

___: same with Amphetamines A E.g. TFMPP or Molly, BZP

Tryptamine

___: E.g. DMT (causes Businessman's lunch), Psilocin

Cathinones

___: Psychoactive designer drugs

fifteen days

Specimens with confirmed positive test results, which are not challenged within ___ after receipt, shall be discarded

one year

A specimen may be kept for a maximum of ___ upon request

5 days

A minimum of ___ for negative specimens

Positive

Negative

Invalid

Computer

1 IDTOMIS = 1 ___